光热治疗
光动力疗法
光敏剂
体内
黑色素瘤
肿瘤消融
脉络膜黑色素瘤
化学
癌症研究
纳米技术
放射治疗
荧光
细胞存活
生物相容性材料
体外
生物医学工程
癌症治疗
烧蚀
临床前影像学
纳米医学
材料科学
光学成像
联合疗法
荧光寿命成像显微镜
癌症
作者
Yingni Xu,Fei Wang,Wenfang Liu,Ruibin Lin,Cheng Liu,Qi Zhao,Guokang He,Guiping Yuan,Weidong Yin,Fei Yu,Jianwei Sun,Ryan T. K. Kwok,Jacky W. Y. Lam,Li Ren,Xuan Zhao,Jin Yuan,Ben Zhong Tang
标识
DOI:10.1007/s40820-026-02077-z
摘要
Choroidal melanoma is a prevalent intraocular malignant tumor with high mortality rate and liver metastases, related to the lack of sensitive and noninvasive therapeutic modalities. To address the imaging diagnostics and therapeutic predicaments for choroidal melanoma, a novel nanoplatform is developed through the integration of an aggregation-induced emission photosensitizer with two-dimensional MXene nanosheets (MX@PEG-MeoTTPy). This nanoplatform simultaneously exhibits distinctive properties and multiple functions including exceptional biocompatibility, efficient type I reactive oxygen species generation, high-quality fluorescence bioimaging, mild near-infrared (NIR) photothermal performance and superior cellular uptake. Furthermore, a thermosensitive hydrogel composite is engineered to encapsulate the nanosheets, enabling controlled and sustained release over 72 h via NIR irradiation and tumor microenvironment-induced gel-sol transition. The nanoplatform leverages synergistic mild photothermal therapy and photodynamic therapy, leading to precise and sustained tumor ablation through pyroptosis-mediated cell death. Both in vitro and in vivo studies validate that the nanosystem serves as an effective theranostic agent for dual-modal imaging-guided synergistic therapy, offering a multifaceted therapeutic strategy for intraocular tumors and showing significant potential for clinical application in choroidal melanoma therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI